Contemporary issues in amblyopia treatment

Optometry

Volumn 76, Issue 10, 2005, Pages 570-578

  Rutstein, Robert P ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Amblyopia; Occlusion; Penalization; Regression; Treatment

Indexed keywords

EID: 27744609080     PISSN: 15291839     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.optm.2005.08.017     Document Type: Article

References (46)

1. Thompson IR, Woodruff G, Hiscox FA, et al. The incidence and prevalence of amblyopia detected in childhood. Public Health 1991;105:455-62.
2. Attebo K, Mitchell P, Cumming R, et al. Prevalence and causes of amblyopia in an adult population. Ophthalmology 1998;105:154-9.
3. Simons K. Amblyopia characterization, treatment, and prophylaxis. Surv Ophthalmol 2005;50:123-66.
4. Hasse W, Wenzel F. The natural course of untreated functional amblyopia: does it progress between childhood and adulthood? Binoc Vis Strabismus Q 1997;12:17-24.
5. Simons K, Preslan M. Natural history of amblyopia untreated owing to lack of compliance. Br J Ophthalmol 1999;83:582-7.
6. Arikan G, Yaman A, Tulin Berk A. Efficacy of occlusion treatment in amblyopia and clinical risk factors affecting the results of treatment. Strabismus 2005;13:63-9.
7. De Buffon G. Dissertation sur la cause du strabisme ou des yeux louches. Mem Acad Roy Sci Paris 1743.
8. Simons K, Gotzler KC, Virtale S. Penalization versus part-time occlusion and binocular outcome in treatment of strabismic amblyopia. Ophthalmology 1997;104:2156-60.
9. Repka MX, Ray JM. The efficacy of optical and pharmacological penalization. Ophthalmology 1993;100:769-74.
10. Pediatric Eye Disease Investigator Group. A randomized trial of atropine vs patching for treatment of moderate amblyopia in children. Arch Ophthalmol 2002;120:268-78.
11. Moke PS, Turpin AH, Beck RW, et al. Computerized method of visual acuity testing: adaptation of the amblyopia treatment study visual acuity testing protocol. Am J Ophthalmol 2001;132:903-9.
12. Pediatric Eye Disease Investigator Group. Two-year follow-up of a 6-month randomized trial of atropine vs patching for treatment of moderate amblyopia in children. Arch Ophthalmol 2005;123:149-57.
13. Oliver M, Neumann R, Chaimovitch Y, et al. Compliance and results of treatment of amblyopia in children more than 8-years-old. Am J Ophthalmol 1986;102:340-5.
14. Rutstein RP, Fuhr PS. Efficacy and stability of amblyopia therapy. Optom Vis Sci 1992;69:747-54.
15. Hug T. Full-time occlusion compared to part-time occlusion for the treatment of amblyopia. Optometry 2004;75:241-4.
16. Repka MX, Beck RW, Holmes JM, et al. A randomized trial of patching regimens for treatment of moderate amblyopia in children. Arch Ophthalmol 2003;121:603-11.
17. Holmes JM, Kraker RT, Beck RW, et al. A randomized trial of patching regimens for treatment of severe amblyopia in children. Ophthalmology 2003;110:2075-87.
18. Simons K, Stein L, Sener EC, et al. Full-time atropine, intermittent atropine, and optical penalization and binocular outcome in treatment of strabismic amblyopia. Ophthalmology 1997;104:2143-55.
19. Pediatric Eye Disease Investigator Group. A randomized trial of atropine regimens for treatment of moderate amblyopia in children. Ophthalmology 2004;111:2076-85.
20. Pediatric Eye Disease Investigator Group. A randomized pilot study of near activities during patching therapy for amblyopia. J Am Assoc Pediatr Ophthalmol Strab 2005;9:129-36.
21. Stewart CE, Moseley MJ, Fielder AR, et al. Refractive adaptation in amblyopia: quantification of effect and implications for practice. Br J Ophthalmol 2004;88:1552-6.
22. Fitzgerald DE, Krumholtz I. Maintenance of improvement gains in refractive amblyopia: a comparison of treatment modalities. Optometry 2002;73:153-9.
23. Leiba H, Shimshoni M, Oliver M, et al. Long-term follow-up of occlusion therapy in amblyopia. Ophthalmology 2001;108:1552-5.
24. Scott WE, Dickey CF. Stability of visual acuity in amblyopic patients after visual maturity. Graefe's Arch Clin Exp Ophthalmol 1988;226:154-7.
25. Ohlsson J, Baumann M, Sjostrand J, et al. Long-term visual outcome in amblyopia treatment. Br J Ophthalmol 2002;86:1148-51.
26. Pediatric Eye Disease Investigator Group. Risk of amblyopia recurrence after cessation of treatment. J Am Assoc Pediatr Ophthalmol Strabiusmus 2004;8:420-8.
27. Iacobucci IL, Archer SM, Furr BA, et al. Bangerter foils in the treatment of moderate amblyopia. Am Orthopt J 2001;51:84-91.
28. Rutstein RP, Daum KM. Anomalies of binocular vision: diagnosis and management, St. Louis: Mosby, 1998.
29. Rutstein RP, Corliss DA. Long-term changes in visual acuity and refractive error in amblyopes. Optom Vis Sci 2004;81:510-5.
30. Epelbaum M, Milleret C, Buisseret P, et al. The sensitive period for strabismic amblyopia in humans. Ophthalmology 1993;100:323-7.
31. Assaf AA. The sensitive period: transfer of fixation after occlusion for strabismic amblyopia. Br J Ophthalmol 1982;66:64-70.
32. Birnbaum MH, Koslowe K, Sanet R. Success an amblyopia therapy as a function of age: a literature survey. Am J Optom Physiol Opt 1977;54:269-75.
33. Flynn JT, Sciffman J, Feuer W, et al. The therapy of amblyopia: an analysis of the results of therapy utilizing the pooled data of published studies. Trans Am Ophthalmol Soc 1998;96:431-50.
34. Wick B, Wingard M, Cotter S, et al. Anisometropic amblyopia: is the patient too old to treat? Optom Vis Sci 1992;69:866-78.
35. Mintz-Hittner HA, Fernandez KM. Successful amblyopia therapy initiated after age 7 years: compliance cures. Arch Ophthalmol 2000;118:1535-41.
36. Mohan K, Saroha V, Sharm A. Successful occlusion therapy for amblyopia in 11 to 15-year-old children. J Pediatr Ophthalmol Strabismus 2004;41:89-95.
37. Park KH, Hwang JM, Ahn JK. Efficacy of amblyopia therapy initiated after 9 years of age. Eye 2004;18:557-8.
38. Pediatric Eye Disease Investigator Group. A prospective, pilot study of treatment of amblyopia in children 10 to less than 18-years-old. Am J Ophthalmol 2004;137:581-3.
39. Pediatric Eye Disease Investigator Group. Randomized trial of treatment of amblyopia in children aged 7 to 17 years. Arch Ophthalmol 2005;123:437-47.
40. Tommila V, Tarkkanen A. Incidence of loss of vision in the healthy eye in amblyopia. Br J Ophthalmol 1981;65:575-7.
41. Vereecken EP, Brabant P. Prognosis for vision in amblyopia after the loss of the good eye. Arch Ophthalmol 1984;102:220-5.
42. Rahi JS, Logan S, Timms C, et al. Risk, causes, and outcomes of visual impairment after loss of vision in the non-amblyopic eye: a population based study. Lancet 2002;360:597-602.
43. Rabin J. Visual improvement in amblyopia after visual loss in the dominant eye. Am J Optom Phys Opt 1984;61:334-7.
44. Hamed LM, Glaser JS, Schatz NJ. Improvement of vision in the amblyopic eye following visual loss in the contralateral normal eye: a report of three cases. Binocul Vis Strabismus Q 1991;6:97-100.
45. Wilson ME. Adult amblyopia reversed by contralateral cataract formation. J Pediatr Ophthalmol Strabismus 1992;29:100-2.
46. Karatza EC, Shields CL, Shields JA. Visual impairment in an adult amblyopic eye following radiation-induced visual loss in the contralateral eye. Arch Ophthalmol 2004;122:126-8.